Format

Send to

Choose Destination
JBI Database System Rev Implement Rep. 2017 Aug;15(8):2055-2059. doi: 10.11124/JBISRIR-2017-003380.

Metformin and Alzheimer's disease, dementia and cognitive impairment: a systematic review protocol.

Author information

1
1Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia 2Monash Centre for Health, Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia 3Discipline of Medicine, National Health and Medical Research Council of Australia (NHMRC) Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, Australia.

Abstract

The objective of the review is to assess the effect of metformin on the risk, progression and severity of Alzheimer's disease and other forms of dementia, as well as any measures of cognitive performance or impairment.

PMID:
28800055
DOI:
10.11124/JBISRIR-2017-003380
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center